Soterix Medical, Inc.
Soterix Medical Inc. (SMI) is a global leader in non-invasive neuromodulation and integrated brain monitoring technology, developing innovative treatments for neuropsychiatric and neurological disorders. Founded in 2008, SMI specializes in clinical trials and has a comprehensive portfolio including High-Definition transcranial Direct Current Stimulation (HD-tDCS), Limited Total Energy tDCS (LTE-tDCS), Neurotargeting software, and innovative devices such as the Artinis Brite Lite fNIRS system. The company provides targeted, portable, and adaptable solutions for clinicians and patients, with multiple clinical approvals worldwide. Soterix Medical is committed to engineering advanced medical technology to serve humanity, supporting research, clinical applications, and innovative therapies.
Industries
Nr. of Employees
small (1-50)
Soterix Medical, Inc.
1480 U.S. 9 N, 204, WOODBRIDGE, NJ 07095
Products
Programmable clinical transcranial stimulation system
A clinical‑grade, programmable transcranial direct current stimulation system configured for multi‑center randomized trials with support for blinded operation, sham programming, electrode-contact monitoring, pause/resume control, and trial-specific data logging.
High‑density multi‑channel transcranial stimulation platform
A multi‑channel high‑density stimulation platform and accessory set designed to deliver focused currents to cortical targets using individualized multi‑electrode montages and neurotargeting workflows.
Remote‑supervised home‑use stimulation platform
A home‑deployable stimulation platform intended for remotely supervised delivery, including subject monitoring, telehealth portal guidance, and connectivity for remote clinician oversight.
Wireless combined stimulation and EEG acquisition system
An untethered system that enables concurrent high‑density electrical stimulation and wireless EEG recording for mobile and naturalistic research environments.
Wearable multi-channel fNIRS systems
Lightweight wireless fNIRS devices for brain and muscle oxygenation monitoring with multi-channel measurement, on-head control, motion sensors, Bluetooth connectivity, and bundled analysis software supporting real-time and offline modes.
Wearable TENS and iontophoresis therapy devices
Over‑the‑counter and clinic-directed wearable TENS devices and battery‑operated iontophoresis systems for symptomatic pain relief and transcutaneous delivery of soluble agents.
Programmable clinical transcranial stimulation system
A clinical‑grade, programmable transcranial direct current stimulation system configured for multi‑center randomized trials with support for blinded operation, sham programming, electrode-contact monitoring, pause/resume control, and trial-specific data logging.
High‑density multi‑channel transcranial stimulation platform
A multi‑channel high‑density stimulation platform and accessory set designed to deliver focused currents to cortical targets using individualized multi‑electrode montages and neurotargeting workflows.
Remote‑supervised home‑use stimulation platform
A home‑deployable stimulation platform intended for remotely supervised delivery, including subject monitoring, telehealth portal guidance, and connectivity for remote clinician oversight.
Wireless combined stimulation and EEG acquisition system
An untethered system that enables concurrent high‑density electrical stimulation and wireless EEG recording for mobile and naturalistic research environments.
Wearable multi-channel fNIRS systems
Lightweight wireless fNIRS devices for brain and muscle oxygenation monitoring with multi-channel measurement, on-head control, motion sensors, Bluetooth connectivity, and bundled analysis software supporting real-time and offline modes.
Wearable TENS and iontophoresis therapy devices
Over‑the‑counter and clinic-directed wearable TENS devices and battery‑operated iontophoresis systems for symptomatic pain relief and transcutaneous delivery of soluble agents.
Services
Software-based individualized montage optimization and current-flow modeling for stimulation dose design, visualization for publications, and protocol support.
Factory- or study-configured stimulators and accessory kits programmed with trial-specific stimulation codes, blinded operation, electrode-quality monitoring, and ongoing engineering support to enable reproducible multi-center trials.
Implementation and operational support for remotely supervised home‑use neuromodulation programs, including patient pre-screening workflows, telehealth portal integration, device kit distribution, and remote session supervision.
Project-based technical integration to combine stimulation with EEG, fMRI, PET, MEG, and fNIRS acquisitions, including synchronization, hybrid holders, and protocol harmonization for combined‑modality experiments.
Design and supply of trial-specific headgear, electrode holders, disposable pads, gels, and accessory kits to standardize electrode placement and reduce operator variability in multi-site studies.
On-site and remote training for device operation and study-specific procedures, staff certification, and partnership program support for clinics adopting stimulation therapies.
Software-based individualized montage optimization and current-flow modeling for stimulation dose design, visualization for publications, and protocol support.
Factory- or study-configured stimulators and accessory kits programmed with trial-specific stimulation codes, blinded operation, electrode-quality monitoring, and ongoing engineering support to enable reproducible multi-center trials.
Implementation and operational support for remotely supervised home‑use neuromodulation programs, including patient pre-screening workflows, telehealth portal integration, device kit distribution, and remote session supervision.
Project-based technical integration to combine stimulation with EEG, fMRI, PET, MEG, and fNIRS acquisitions, including synchronization, hybrid holders, and protocol harmonization for combined‑modality experiments.
Design and supply of trial-specific headgear, electrode holders, disposable pads, gels, and accessory kits to standardize electrode placement and reduce operator variability in multi-site studies.
On-site and remote training for device operation and study-specific procedures, staff certification, and partnership program support for clinics adopting stimulation therapies.
Expertise Areas
- Non-invasive neuromodulation research and device engineering
- Clinical trial design and execution for neuromodulation
- Individualized dose design and current‑flow neurotargeting
- Multimodal neuroimaging integration (EEG, fMRI, PET, MEG, fNIRS)
Key Technologies
- Transcranial direct current stimulation (tDCS / tES)
- High-definition multi-electrode stimulation (HD-tES)
- Adaptive limited‑total‑energy stimulation (LTE)
- Remote‑supervised home‑use stimulation platforms
News & Updates
Soterix Medical received FDA clearance for its intraoperative neurophysiologic monitoring system, MEGA-IOM.
Launch of a combined HD-tES and EEG system with untethered design for research in mobile environments.
A clinical trial evaluating remote tDCS and brain training for long COVID.
A clinical trial of home-based taVNS for post-COVID neuropsychiatric symptoms.
Expanded trials of neuromodulation technologies for Alzheimer's and MCI.
Approval to launch a trial of at-home tDCS-LTE for depression.
Soterix Medical received FDA clearance for its intraoperative neurophysiologic monitoring system, MEGA-IOM.
Launch of a combined HD-tES and EEG system with untethered design for research in mobile environments.
A clinical trial evaluating remote tDCS and brain training for long COVID.
A clinical trial of home-based taVNS for post-COVID neuropsychiatric symptoms.
Expanded trials of neuromodulation technologies for Alzheimer's and MCI.
Approval to launch a trial of at-home tDCS-LTE for depression.